Clinical trial

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

NCT01663116

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2019-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritis Aggravatedunresolved

Interventions

Stem cellsGENETIC

PlaceboGENETIC

Sponsors & collaborators

Tigenix S.A.U.lead sponsor

Mapped research locations

MadridSpain4 BarcelonaSpain3 ValenciaSpain2 SevilleSpain2 GranadaSpain2 MálagaSpain1 A CoruñaSpain1 CórdobaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01663116 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.